ENSG The Ensign Group, Inc.
XNAS 181.48 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
ENSG
$181.48
—
What changed
Recent filings, trades and movesKey stats
$181.48
- 52-Week Range
- $141.58 – $218.00
- YTD
- +4.35%
- IV Rank (30D)
- 20.3
- Straddle Price
- $14.55
- P/C Vol Ratio
- 0.49
- Market Cap
- $10.6B
- Open
- $181.66
- Day Range
- $180.46 – $183.24
- Volume
- 154,088
- Prev Close
- $181.08
Fair Value
MODEL: NEUTRAL
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 0.63 |
| Cost of Equity (CAPM) | 8.04% (VRP-adj) |
| WACC | 8.06% |
| Volatility Risk Premium | +11.2pp (IV − HV30) |
| Effective Tax Rate | 25.0% |
| Rev. Growth (YoY, DCF input) | +9.1% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.09 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.5B |
| Return on Equity (TTM) | 15.6% |
| Book / Price | 23.9% |
| Gross Margin (TTM) | 23.1% |
| FCF Margin (TTM) | 9.0% |
| Debt / Equity | 0.08 |
| Quality Score | 3/6 — normal (10y DCF) |
| Market-Implied Growth | +4.5% (reverse-DCF on current price) |
| SMA 50 | $175.21 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $178.28 |
| Bollinger Width / SMA20 | 10.6% (drives anchor stability) |
| Net Debt | $-0.1B |
| Market Cap | $11B |
Peers used for multiples: CHE, EHC, HCA, LLY, MSA, THC, UNH, USPH
60-Day Conviction
4%
20-Day Fair Value
≈ by Dec 8, 2026
$181.61
α +0.0%
rank 11%
conviction
2%
40-Day Fair Value
≈ by Jan 6, 2027
$182.56
α +0.6%
rank 21%
conviction
22%
60-Day Fair Value
≈ by Feb 4, 2027
$181.84
α +0.2%
rank 16%
conviction
4%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $237.97 | 19% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $169.05 | 9% | median 23.1× · 8 peers |
| Peer EV/EBITDA | $182.04 | 9% | median 15.5× · 8 peers |
| Peer P/B | $197.54 | 2% | median 4.6× · 7 peers |
| Peer P/S | $207.68 | 6% | median 2.0× · 8 peers |
| Market Anchor (SMA50) | $175.21 | 37% | stability 97% (BB-width) |
| Options Expected (B-L 30d) | $181.37 | 18% | 19 strikes · skew -0.27 |
As of 2026-11-09 · updated
Related
About
- Industry (SIC)
- SERVICES-SKILLED NURSING CARE FACILITIES (8051) · industry map
- Exchange
- XNAS
- Market Cap
- $10.6B
- Employees
- 46,000
- List Date
- 2007-11-09
- CIK
- 0001125376
- Last Earnings
- Oct 27 after close · +8.6% vs ±7.8% expected
- Next Earnings
- ~Feb 3, 2027 (estimated)
- Headquarters
- San Juan Capistrano, CA
- Homepage
- https://www.ensigngroup.net
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its capti…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 3.90% | -11.54% | -1.33% | -1.25% | 5.11% | -1.30% | -1.07% |
| Feb | -3.28% | 12.70% | -4.80% | 8.30% | -9.32% | 24.11% | 4.62% |
| Mar | 12.76% | 8.63% | 5.59% | 2.07% | -0.36% | -6.64% | 3.68% |
| Apr | -8.43% | -14.75% | 2.03% | -4.45% | -1.12% | -6.70% | -5.57% |
| May | -4.84% | 2.62% | -8.88% | 1.50% | 14.95% | -8.75% | -0.57% |
| Jun | 3.28% | -5.98% | 7.90% | 3.27% | 4.19% | -2.85% | 1.64% |
| Jul | -4.27% | 5.28% | 3.17% | 13.38% | -0.52% | 7.61% | 4.11% |
| Aug | -3.21% | 4.19% | 5.83% | 8.47% | 13.20% | -2.80% | 4.28% |
| Sep | -9.72% | -5.37% | -6.25% | -2.90% | 0.14% | -0.69% | -4.13% |
| Oct | 3.16% | 10.23% | 4.95% | 6.76% | 3.24% | 7.01% | 5.89% |
| Nov | -2.49% | 3.61% | 10.94% | -5.26% | 0.90% | 1.40%* | 1.52% |
| Dec | 12.20% | 0.28% | 3.44% | -8.47% | -5.14% | -- | 0.46% |
| Total | -3.72% | 5.90% | 22.66% | 20.87% | 25.33% | 6.61% | 12.94% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $178.66
SMA 50: $175.38
SMA 200: $181.76
Current: $181.54
EMA 12: $180.84
EMA 26: $178.56
MACD: 2.2719 | Signal: 0.3591
BULLISH
ADX (14): 13.68
RANGE
+DI: 26.27
−DI: 19.09
Momentum Oscillators
RSI (14): 53.57
NEUTRAL
Stoch %K: 61.38
Stoch %D: 70.18
Williams %R: -39.22
Volume & Volatility
BB Upper: $187.99
BB Lower: $169.33
NEUTRAL
OBV: -15,142,605
Vol SMA 20: 402,944
Vol ROC: -68.74%
ATR: $5.30
True Range: $2.78
HV 20: 44.0%
HV 30: 37.4%
HV 60: 29.3%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Written before ENSG’s Oct 27 earnings report, so it doesn’t reflect the results.
THE ENSIGN GROUP, INC. (ENSG) - COMPREHENSIVE STOCK ANALYSIS
Executive Summary
Overall Assessment: BEARISH | Confidence Level: 7/10
The Ensign Group faces significant near-term headwinds driven by multiple securities class action lawsuits that dominate recent news flow (5 of 6 headlines reference litigation). While technical indicators suggest a range-bound consolidation rather than a directional breakdown, the negative beta (-0.05) creates defensive characteristics that may limit downside in a rising market, but the litigation catalyst poses material downside risk. The stock is trading slightly below its 20-day and 50-day moving averages, suggesting early-stage weakness in a range-bound regime.
Investment Thesis: ENSG faces near-term litigation risk with class action deadlines creating time-sensitive pressure. The stock's inverse market correlation and low ADX (10.44) indicate weak directional momentum, creating a consolidation environment where litigation news serves as the primary catalyst. Neutral technical momentum combined with bearish options sentiment (7.71 put/call ratio) suggests downside risk outweighs upside potential in the next 4-8 weeks.
Recent News Sentiment Impact: Overwhelmingly negative. Five of six recent headlines reference securities class actions with urgent investor deadline language ("Secure Counsel Before Important Deadline"). This coordinated legal activity creates sustained negative pressure and signals potential material adverse news flow. The frequency and urgency of these filings suggest litigation is an active, developing story rather than a resolved matter.
Technical Analysis
Trend Direction
-
Short-term (1-4 weeks): Neutral/Downtrend initiation
- Price ($173.26) trading below SMA 20 ($173.57) and SMA 50 ($175.78)
- Negative MACD histogram (-0.81) with MACD below signal line indicates early bearish momentum formation
- ADX at 10.44 confirms weak directional bias—more consolidation than trend
-
Medium-term (1-3 months): Downtrend
- Price significantly below SMA 200 ($181.59), representing 4.6% gap to longer-term resistance
- EMA 12 ($172.67) below EMA 26 ($173.39)—bearish alignment
- Stock has broken below intermediate support levels
-
Long-term (3-12 months): Downtrend established
- 200-day MA at $181.59 suggests established resistance; price 4.6% below this level
- No evidence of major support levels above current price; next technical support would require testing lower zones
Support/Resistance Levels
| Level | Type | Proximity | Note | |-------|------|-----------|------| | $177.97 | Resistance | +2.7% | Bollinger Band upper, SMA 20 nearby | | $175.78 | Resistance | +1.5% | SMA 50 - intermediate trend | | $173.57 | Resistance/Pivot | -0.04% | SMA 20 - immediate resistance, current price | | $173.26 | Current Price | — | Neutral positioning relative to short-term MAs | | $169.16 | Support | -2.4% | Bollinger Band lower - initial technical support | | $165-166 | Support Zone | -4.5% | Estimated psychological/technical support | | $181.59 | Strong Resistance | +4.8% | SMA 200 - major trend resistance |
Momentum Signals
RSI (14): 49.59 - Neutral Territory
- Reading sits precisely in the middle of the 30-70 range
- Indicates no overbought or oversold condition
- Suggests balanced buying/selling pressure with no extreme momentum
- Slight downward pressure expected before any meaningful reversal signal
MACD: -0.73 / Signal: 0.08 / Histogram: -0.81 - Bearish Signal
- MACD line (-0.73) trading below signal line (0.08) = bearish momentum
- Negative histogram (-0.81) confirms momentum is negative and widening
- Configuration suggests early-stage bearish momentum development, not an oversold exhaustion
- Critical watch: First bullish signal would be MACD crossing above signal line
Bollinger Bands Position: Neutral Squeeze
- Price at $173.26 sits close to middle band ($173.57)—central position
- Width of 5.08 is relatively narrow (not in extreme squeeze)
- Upper band at $177.97 (+2.7%) and lower band at $169.16 (-2.4%) represent modest volatility range
- Neutral stance with slight bias toward testing lower band given MACD bearish signal
Williams %R: -51.19
- Positioned near middle of -100 to 0 scale
- Suggests no extremes in momentum, consistent with RSI neutrality
- Stochastic %K (45.86) and %D (36.55) also show neutral, slightly weak positioning
Momentum Assessment: Mixed signals with slight bearish lean. RSI neutral but MACD already bearish suggests early downside momentum forming without oversold conditions that typically attract buyers.
Volume Analysis
Volume Trends - NEGATIVE SIGNALS:
- Volume SMA 20: 365,821 shares average
- Volume Rate of Change: -18.03% YoY — declining trend in trading activity
- On-Balance Volume (OBV): -19,755,943 — significantly negative, indicating selling pressure exceeds buying
- Interpretation: Declining volume combined with negative OBV suggests weakness is not accompanied by strong conviction from institutional buyers. Volume erosion indicates loss of buying support, typically precedes further weakness.
Institutional Interest Signal:
- Low volume (down 18% on rolling basis) with negative OBV indicates institutions are not accumulating on weakness
- Litigation news may be causing institutional exit, not entry
- Lack of volume support on price weakness reduces likelihood of sustained reversal
News & Sentiment Analysis
Recent Headlines Summary
Litigation Cluster (5 of 6 headlines | 83% of news flow):
All recent significant news centers on securities class action lawsuits:
- Rosen Law Firm (2026-10-11): Encourages ENSG investors to secure counsel before important deadline
- Bernstein Liebhard (2026-10-09): Investor alert for ENSG large-loss shareholders
- Gainey McKenna & Egleston (2026-10-09): Class action lawsuit formally filed against ENSG
- Rosen Law Firm (2026-10-09): Multiple filings encouraging ENSG investors to secure counsel
Pattern Analysis:
- Multiple law firms filing simultaneously suggests coordinated class action environment
- "Important Deadline" language appears repeatedly—suggests statute of limitations pressure for class representatives
- No company response or defense information visible in news flow
- Unrelated headline: Better Home & Finance (BETR) also has Rosen litigation (suggests potential sector-wide issue or coordinated legal campaign)
Sentiment Assessment
Aggregate Sentiment: NEGATIVE (100% of ENSG-specific headlines)
- 5/5 ENSG-specific headlines marked as NEGATIVE
- Legal urgency language creates psychological pressure on retail and institutional holders
- No offsetting positive news catalysts visible in recent flow
Catalyst Identification:
| Catalyst | Timeline | Impact Potential | |----------|----------|------------------| | Class Action Deadlines | Immediate (1-7 days) | CRITICAL - Repeated "important deadline" language suggests imminent deadlines | | Earnings Release | 2026-11-02 (3+ weeks) | Medium - Could address litigation questions but likely overshadowed | | Litigation Discovery/Motions | Ongoing | Medium - Future news flow likely negative as litigation details emerge | | Settlement Discussions | Unknown | Medium-High - First positive catalyst would be settlement announcement |
Catalyst Timing Note: The cluster of litigation headlines from Oct 9-11, 2026 appears correlated with formal class action filing dates. This suggests litigation news will likely remain active headline generator for 3-6 months through discovery phase.
Market Narrative
Litigation Narrative vs. Technical Signals - CONTRADICTION:
| Signal Type | Message | Conflict | |-------------|---------|----------| | News Sentiment | Material corporate governance/disclosure issue requiring legal intervention | Suggests stock should decline significantly | | Technical Trend | Weak downtrend with low momentum (ADX 10.44), range-bound consolidation | Suggests downside is grad
Generated
News
All ENSG news →
CEO Barry Port discusses record Q3 revenue and raised guidance.
Showing 1–10 of 12
Page 1 of 2
Earnings History
15 of 19 under expected move
Avg Expected Move
6.78%
Avg Actual Move
4.13%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-03 | After-Close | 8.37% | 2.65% | 0.32x | Within |
| 2021-04-29 | After-Close | 6.96% | 0.96% | 0.14x | Within |
| 2022-02-09 | After-Close | 7.79% | 5.32% | 0.68x | Within |
| 2022-10-26 | After-Close | 6.33% | 3.97% | 0.63x | Within |
| 2023-02-02 | After-Close | 3.46% | 1.68% | 0.49x | Within |
| 2023-04-26 | After-Close | 7.27% | 3.59% | 0.49x | Within |
| 2023-07-27 | After-Close | 7.22% | 2.94% | 0.41x | Within |
| 2023-10-25 | After-Close | 6.63% | 0.33% | 0.05x | Within |
| 2024-02-01 | After-Close | 5.01% | 4.71% | 0.94x | Within |
| 2024-05-01 | After-Close | 6.56% | 2.43% | 0.37x | Within |
| 2024-07-25 | After-Close | 6.98% | 4.87% | 0.70x | Within |
| 2024-10-24 | After-Close | 7.26% | 2.67% | 0.37x | Within |
| 2025-02-05 | After-Close | 5.98% | 8.70% | 1.45x | Exceeded |
| 2025-04-29 | After-Close | 6.40% | 0.68% | 0.11x | Within |
| 2025-07-24 | After-Close | 7.26% | 8.92% | 1.23x | Exceeded |
| 2025-11-03 | After-Close | 6.99% | 0.05% | 0.01x | Within |
| 2026-02-04 | After-Close | 6.90% | 13.85% | 2.01x | Exceeded |
| 2026-04-30 | After-Close | 7.69% | 1.59% | 0.21x | Within |
| 2026-10-27 | After-Close | 7.85% | 8.62% | 1.10x | Exceeded |
Earnings calendar: this week’s reports with expected vs actual moves →
ENSG Options Activity & IV Rank
ENSG IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 30.5%
7-DTE IV: 34.1%
Expected Move: $14.55
7-DTE Move: $8.95
Days to Exp: 39 (2026-12-18)
Options Flow · All expiries
Call Volume: 517
Put Volume: 256
P/C Volume: 0.495
BULLISH
Call OI: 3,441
Put OI: 667
P/C OI: 0.194
Total OI: 4,108
ATM Options Pricing
ATM Call: $8.65
ATM Put: $5.90
Call %: 4.8%
Put %: 3.3%
Chain Summary
Chain Volume: 773
Chain OI: 4,108
Last Updated: 11/9/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 84th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
84%
vs own history
GEX tilt
+0.89
OI-weighted, today
Vanna tilt
+0.90
δ-sensitivity to IV
Charm tilt
-0.88
δ-decay vs time
Vanna tilt +0.90: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.88: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 16 ATM contracts, 3k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)20.3LowNov 9
IV Rank (30 DTE)20.3LowNov 9
Straddle Price (30 DTE)$14.55Nov 9
Beta Analysis
Risk Metrics
Beta: 0.0317
Alpha: 4.83%
Correlation: 0.0146
R-Squared: 0.0%
Stock Volatility: 29.8%
Market Volatility: 13.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own ENSG
6 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Point72 Hedge fund Steve Cohen | $49.8M | #328 of 1945 | +3491.9% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $38.3M | #747 of 3716 | +269.6% | 13F | |
| Citadel Hedge fund Ken Griffin | $24.9M | #1026 of 6285 | +697.7% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $5.7M | #1391 of 3138 | +65.0% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $2.0M | #714 of 997 | +94.3% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $357K | #2267 of 4729 | -9.6% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ENSG Institutional Ownership (13F)
Filings for 2026-06-30 · 258 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 59,446,750 (as of 2026-09-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
8 filers$67.34M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Jane Street Group, LLC Custodian | $42.98M | 63.82% | 2026-06-30 |
| 2 | IMC-Chicago, LLC Custodian | $7.24M | 10.75% | 2026-09-30 |
| 3 | Susquehanna International Group, LLP Custodian | $6.99M | 10.38% | 2026-06-30 |
| 4 | LANDMARK INVESTMENT PARTNERS, L.P. | $3.98M | 5.90% | 2026-06-30 |
| 5 | Citadel Advisors LLC Custodian | $2.31M | 3.43% | 2026-06-30 |
| 6 | Simplex Trading, LLC Custodian | $1.87M | 2.78% | 2026-09-30 |
| 7 | BRANT POINT INVESTMENT MANAGEMENT LLC | $1.60M | 2.38% | 2026-06-30 |
| 8 | GROUP ONE TRADING LLC Custodian | $368.69K | 0.55% | 2026-06-30 |
6 filers$45.00M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Wells Fargo & Company Custodian | $35.27M | 78.37% | 2026-06-30 |
| 2 | Susquehanna International Group, LLP Custodian | $5.72M | 12.72% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $2.98M | 6.63% | 2026-06-30 |
| 4 | PEAK6 LLC | $528.99K | 1.18% | 2026-06-30 |
| 5 | IMC-Chicago, LLC Custodian | $481.60K | 1.07% | 2026-09-30 |
| 6 | Simplex Trading, LLC Custodian | $17.20K | 0.04% | 2026-09-30 |
ENSG Insider Trading (Form 4)
Latest: 2026-11-06Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-06 | Pison Marivic Uychiat | Director | Mixed Grant +1,600 · Tax −163 |
+1,437 | $182.39 | -$29.7K | EDGAR |
| 2026-10-19 | Ann Scott Blouin | Director | Award (A) | +600 | — | EDGAR | |
| 2026-10-19 | Barry M Smith | Director | Award (A) | +600 | — | EDGAR | |
| 2026-10-19 | John O Agwunobi | Director | Award (A) | +600 | — | EDGAR | |
| 2026-10-19 | Daren Shaw | Director | Award (A) | +600 | — | EDGAR | |
| 2026-10-19 | Swati Bargotra Abbott | Director | Award (A) | +600 | — | EDGAR | |
| 2026-10-19 | Mark Vincent Parkinson | Director | Mixed Grant +600 · Sell −100 |
+500 | $179.62 | -$18.0K | EDGAR |
| 2026-09-14 | Pison Marivic Uychiat | Director | Gift (G) | −580 | — | EDGAR | |
| 2026-08-13 | Spencer Burton | President and COO | Gift (G) | −2,500 | — | EDGAR | |
| 2026-07-29 | Ann Scott Blouin | Director | Sell (S) | −375 | $183.54 | -$68.8K | EDGAR |
| 2026-07-22 | John O Agwunobi | Director | Sell (S) | −392 | $171.06 | -$67.1K | EDGAR |
| 2026-07-17 | Swati Bargotra Abbott | Director | Award (A) | +600 | — | EDGAR | |
| 2026-07-17 | Ann Scott Blouin | Director | Award (A) | +600 | — | EDGAR | |
| 2026-07-17 | Daren Shaw | Director | Award (A) | +600 | — | EDGAR | |
| 2026-07-17 | Mark Vincent Parkinson | Director | Mixed Sell −100 · Grant +600 |
+500 | $168.12 | -$16.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
ENSG Insider Holdings
13 insiders · @ $181.54
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Suzanne D. Snapper | CFO | 349,265 | $63.41M | -$24.87M | 109 | 2026-05-28 |
| 2 | Barry Port | Chief Executive Officer | 231,264 | $41.98M | -$390.00M | 106 | 2026-05-28 |
| 3 | Christopher R. Christensen | Executive Chairman | 200,532 | $36.40M | -$6.29B | 86 | 2025-05-29 |
| 4 | Chad Keetch | CIO and EVP | 110,041 | $19.98M | -$12.24M | 81 | 2026-05-28 |
| 5 | Spencer Burton | President and COO | 65,970 | $11.98M | -$6.06M | 50 | 2026-08-13 |
| 6 | Beverly B. Wittekind | VP and Chief Legal Officer | 33,135 | $6.02M | -$12.08M | 80 | 2026-05-28 |
| 7 | Daren Shaw | Director | 25,526 | $4.63M | -$6.66M | 84 | 2026-10-19 |
| 8 | Ann Scott Blouin | Director | 24,277 | $4.41M | -$486.3K | 42 | 2026-10-19 |
| 9 | Barry M Smith | Director | 22,552 | $4.09M | -$2.04M | 68 | 2026-10-19 |
| 10 | Swati Bargotra Abbott | Director | 21,432 | $3.89M | -$152.4K | 29 | 2026-10-19 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ENSG Board & Officers
As of SEC filings through Nov 6, 2026Directors 9
- Daren Shaw · since Apr 3, 2012
- Barry M Smith · since May 29, 2014
- Ann Scott Blouin · since Nov 28, 2018
- Barry Port · listed since May 2019
- Swati Bargotra Abbott · since Jan 1, 2020
- Suzanne D. Snapper · listed since Feb 2022
- John O Agwunobi · since Jan 1, 2023
- Mark Vincent Parkinson · since Oct 21, 2024
- Pison Marivic Uychiat · since Sep 1, 2025
Officers 5
- Barry Port · Chief Executive Officer · listed since May 2019
- Spencer Burton · President and COO · since May 30, 2019
- Suzanne D. Snapper · CFO · listed since May 2021
- Beverly B. Wittekind · VP and Chief Legal Officer · listed since May 2025
- Chad Keetch · CIO and EVP · listed since May 2026
Changes in the last 10 years (22)
| May 19, 2026 | Chad Keetch listed as CIO and EVP (previously CIO, EVP and Secretary) in SEC filings |
| Sep 1, 2025 | Pison Marivic Uychiat became a director |
| Jun 17, 2025 | The company announced the departure of Christopher R. Christensen from the board in an SEC filing |
| Jun 17, 2025 | The company announced the departure of Christopher R. Christensen as Executive Chairman in an SEC filing |
| May 19, 2025 | Beverly B. Wittekind listed as VP and Chief Legal Officer (previously VP and General Counsel) in SEC filings |
| Oct 21, 2024 | Mark Vincent Parkinson became a director |
| Jan 1, 2023 | John O Agwunobi became a director |
| Dec 31, 2022 | Lee A Daniels left the board, per their own SEC filing |
| Feb 10, 2022 | Suzanne D. Snapper first listed as a director in an SEC filing |
| May 27, 2021 | Suzanne D. Snapper listed as CFO (previously CFO and EVP) in SEC filings |
| Jan 1, 2020 | Swati Bargotra Abbott became a director |
| Dec 31, 2019 | John G. Nackel left the board, per their own SEC filing |
| Jun 3, 2019 | Christopher R. Christensen listed as Executive Chairman (previously President and CEO) in SEC filings |
| May 31, 2019 | Suzanne D. Snapper listed as CFO and EVP (previously CFO) in SEC filings |
| May 31, 2019 | Chad Keetch listed as CIO, EVP and Secretary (previously Executive VP and Secretary) in SEC filings |
| May 31, 2019 | Barry Port listed as Chief Executive Officer (previously Vice President) in SEC filings |
| May 31, 2019 | Barry Port first listed as a director in an SEC filing |
| May 30, 2019 | Spencer Burton became President and COO |
| Nov 28, 2018 | Ann Scott Blouin became a director |
| Jan 16, 2018 | Antoinette T. Hubenette reported in an SEC filing no longer being a director |
| Nov 2, 2017 | Malene Davis became a director |
| Jan 5, 2017 | Chad Keetch listed as Executive VP and Secretary (previously Executive Vice President) in SEC filings |
Not reported recently (1)
- Malene Davis · Last reported as a director in an SEC filing dated Jul 18, 2018
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ENSG Proposed Insider Sales (Form 144)
Latest: 2026-10-16
? Form 144 Guide
Last 30d:
1 filing
· $18K notice value
· Last 90d:
1 filing
· $18K notice value
· 1 unique filer
· 100% under 10b5-1 plans
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Parkinson Mark Vincent (1, $18K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-10-16 | Parkinson Mark Vincent | Director | 100 | $18.0K | 2026-10-16 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-07-27 | Blouin Ann Scott | Director | 375 | $68.8K | 2026-07-27 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-07-20 | Agwunobi John O | Director | 392 | $67.1K | 2026-07-20 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-07-16 | Parkinson Mark Vincent | Director | 100 | $16.8K | 2026-07-16 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-06-02 | SMITH BARRY M | Director | 700 | $115.0K | 2026-06-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-05-04 | SMITH BARRY M | Director | 700 | $127.5K | 2026-05-04 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-04-20 | Agwunobi John O | Director | 392 | $78.4K | 2026-04-20 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-04-16 | Parkinson Mark Vincent | Director | 100 | $19.7K | 2026-04-16 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-04-02 | SMITH BARRY M | Director | 700 | $137.7K | 2026-04-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2026-03-02 | SMITH BARRY M | Director | 700 | $149.1K | 2026-03-02 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-10-27
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-10-27 | Earnings results | EDGAR |
| 2026-08-25 | Bylaws or fiscal year change | EDGAR |
| 2026-08-20 | Material agreement · New debt obligation · Regulation FD disclosure | EDGAR |
| 2026-07-27 | Earnings results | EDGAR |
| 2026-06-15 | Other events | EDGAR |
| 2026-06-10 | Other events | EDGAR |
| 2026-05-18 | Shareholder vote results | EDGAR |
| 2026-04-30 | Earnings results | EDGAR |
| 2026-02-04 | Earnings results | EDGAR |
| 2025-11-03 | Earnings results | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-04 | 0001125376-26-000007 | EDGAR |
| 2025-02-05 | 0001125376-25-000021 | EDGAR |
| 2024-02-01 | 0001125376-24-000018 | EDGAR |
| 2023-02-02 | 0001125376-23-000018 | EDGAR |
| 2022-02-09 | 0001125376-22-000019 | EDGAR |
| 2021-02-03 | 0001125376-21-000020 | EDGAR |
| 2020-02-05 | 0001125376-20-000018 | EDGAR |
| 2019-02-06 | 0001125376-19-000016 | EDGAR |
| 2018-02-08 | 0001125376-18-000028 | EDGAR |
| 2017-02-08 | 0001125376-17-000013 | EDGAR |
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
| Filing Date | Accession | Link |
|---|---|---|
| 2026-10-27 | 0001125376-26-000046 | EDGAR |
| 2026-07-27 | 0001125376-26-000034 | EDGAR |
| 2026-04-30 | 0001125376-26-000021 | EDGAR |
| 2025-11-03 | 0001125376-25-000170 | EDGAR |
| 2025-07-24 | 0001125376-25-000142 | EDGAR |
| 2025-04-29 | 0001125376-25-000075 | EDGAR |
| 2024-10-24 | 0001125376-24-000171 | EDGAR |
| 2024-07-25 | 0001125376-24-000135 | EDGAR |
| 2024-05-01 | 0001125376-24-000064 | EDGAR |
| 2023-10-25 | 0001125376-23-000184 | EDGAR |
ETF Holders
141 ETFs hold ENSG
25 shown · $1.84B total exposure · 0.17% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | IJH iShares Core S&P Mid-Cap ETF | iShares (BlackRock) | 0.31% | $378.7M | $121.4B | 2026-11-06 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $302.4M | — | 2026-09-30 |
| 3 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.12% | $214.4M | — | 2026-09-30 |
| 4 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.27% | $119.2M | — | 2026-09-30 |
| 5 | VXF Vanguard Extended Market ETF | Vanguard | 0.12% | $111.9M | — | 2026-09-30 |
| 6 | MDY State Street® SPDR® S&P MIDCAP 400® ETF Trust | SPDR (State Street) | 0.31% | $80.5M | $25.6B | 2026-11-05 |
| 7 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.19% | $64.6M | — | 2026-11-05 |
| 8 | IJK iShares S&P Mid-Cap 400 Growth ETF | iShares (BlackRock) | 0.63% | $63.8M | $10.2B | 2026-11-06 |
| 9 | SPMD State Street® SPDR® Portfolio S&P 400™ Mid Cap ETF | SPDR (State Street) | 0.32% | $57.9M | $18.3B | 2026-11-05 |
| 10 | VIG Vanguard Dividend Appreciation ETF | Vanguard | 0.04% | $56.2M | — | 2026-09-30 |
| 11 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.21% | $47.5M | — | 2026-08-31 |
| 12 | SDVY First Trust SMID Cap Rising Dividend Achievers ETF | First Trust | 0.42% | $46.8M | $11.1B | 2026-11-06 |
| 13 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.08% | $43.7M | $56.9B | 2026-11-06 |
| 14 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.04% | $33.8M | — | 2026-11-05 |
| 15 | VHT Vanguard Health Care ETF | Vanguard | 0.14% | $29.9M | — | 2026-09-30 |
| 16 | SCHM Schwab U.S. Mid-Cap ETF | Nport | 0.19% | $27.6M | — | 2026-08-31 |
| 17 | REGL ProShares S&P MidCap 400 Dividend Aristocrats ETF | ProShares | 1.56% | $27.1M | — | 2026-11-06 |
| 18 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.03% | $22.5M | $82.9B | 2026-11-06 |
| 19 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 1.30% | $19.8M | $1.5B | 2026-11-06 |
| 20 | OSCV Opus Small Cap Value ETF | Nport | 2.49% | $17.6M | — | 2026-07-31 |
| 21 | MDYG State Street® SPDR® S&P 400™ Mid Cap Growth ETF | SPDR (State Street) | 0.64% | $17.3M | $2.7B | 2026-11-05 |
| 22 | IVOO Vanguard S&P Mid-Cap 400 ETF | Vanguard | 0.29% | $16.6M | — | 2026-09-30 |
| 23 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.10% | $14.8M | $14.8B | 2026-11-06 |
| 24 | FFSM Fidelity Fundamental Small-Mid Cap ETF | Nport | 0.91% | $13.6M | — | 2026-07-31 |
| 25 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.01% | $13.5M | $93.2B | 2026-11-06 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
27.02
TTM Diluted EPS
$6.72
TTM Revenue
$5.67B
TTM Net Income
$399.12M
TTM Op. Cash Flow
$695.67M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-30 | $1.48B | $104.26M | $1.76 | $240.24M |
| Q2 '26 | 2026-06-30 | $1.44B | $99.74M | $1.68 | $171.95M |
| Q1 '26 | 2026-03-31 | $1.39B | $99.67M | $1.67 | $100.15M |
| Q4 '25 | 2025-12-31 | $1.36B | $95.45M | $1.61 | $183.32M |
| Q3 '25 | 2025-09-30 | $1.30B | $83.84M | $1.42 | $153.00M |
| Q2 '25 | 2025-06-30 | $1.23B | $84.40M | $1.44 | $155.73M |
| Q1 '25 | 2025-03-31 | $1.17B | $80.28M | $1.37 | $72.22M |
| Q4 '24 | 2024-12-31 | $1.13B | $79.69M | $1.36 | $100.46M |
| Q3 '24 | 2024-09-30 | $1.08B | $78.44M | $1.34 | $134.48M |
| Q2 '24 | 2024-06-30 | $1.04B | $71.01M | $1.22 | $76.94M |
| Q1 '24 | 2024-03-31 | $1.01B | $68.83M | $1.19 | $35.31M |
| Q4 '23 | 2023-12-31 | $980.38M | $21.69M | $0.37 | $85.27M |
Q3 2026 • period ending 2026-09-30 • filed 2026-10-27
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
27.02
P/B
4.40
P/S
1.96
EV/EBITDA
18.26
EV/Sales
1.94
ROE
15.5%
ROA
6.6%
Div Yield
0.14%
FCF Yield
5.66%
Debt/Equity
0.06
Current Ratio
—
Market Cap
$10.75B
as of 2026-11-09
ENSG vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| LLY Eli Lilly & Co. | $1.21T | 45.9 | +45.5% | +31.0% | 27 |
| UNH UNITEDHEALTH GROUP INCORPORATED (Delawar | $353.2B | 30.0 | +9.7% | +18.0% | 45 |
| HCA HCA Healthcare, Inc. | $103.4B | 16.7 | +5.8% | +7.2% | 19 |
| THC Tenet Healthcare Corporation New | $22.5B | 8.5 | +8.3% | +46.3% | 27 |
| EHC Encompass Health Corporation Common Stoc | $13.5B | 22.0 | +9.4% | +32.0% | 19 |
| ENSG The Ensign Group, Inc. | $10.6B | 27.0 | +17.5% | +4.4% | 20 |
| CHE Chemed Corporation | $6.8B | 25.8 | +5.2% | +27.3% | 53 |
| MSA Mine Safety Incorporated | $6.6B | 22.3 | +8.1% | +6.8% | 46 |
| USPH US Physical Therapy Inc | $1.5B | — | +10.4% | +26.6% | 16 |
| Peer median | $18.0B | 22.3 | +8.9% | +26.9% | 27 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
1.39M
SI % of Float
2.49%
Days to Cover
4.04
Short Vol Ratio
42.5%
Free Float
55.91M
Float %
95.9%
Short interest 2026-10-15 • Short volume 2026-11-06 • Float 2026-08-24